期刊文献+

护心康对动脉粥样硬化兔NF-κB的干预作用 被引量:5

Intervention effect of Huxinkang on NF- κB in atherosclerosis rabbits
原文传递
导出
摘要 目的研究护心康防治动脉粥样硬化的作用机制。方法采用高脂喂饲复制兔动脉粥样硬化模型,将护心康分为低、中、高剂量3个剂量组进行干预治疗,检测给药后动脉管壁NF-κB的变化。结果护心康中、高剂量组NF-κB均较模型组低(P<0.05);低剂量组和模型组之间差异无统计学意义(P>0.05);高剂量组和中剂量组之间差异无统计学意义(P>0.05)。结论护心康具有降低动脉管壁NF-κB的作用。 Objective To explore the mechanism of Huxinkang in prevention and treatment of atherosclerosis. Methods Ninety male Chinese white rabbits were randomly divided into 5 groups: the normal control group,the model group,Huxinkang low-,middle- and high- dose groups. The rabbits of each group were fed with high cholesterol diet for 63 days except rabbits of the normal control group. The samples of aorta were taken for detecting the changes of nuclear transcription factor- κB( NF- κB)in the AS plaque. Results The expression of NF- κB in AS plaque was decreased in the middle- and high- dose groups compared with the model group( P 〈0. 05). And no statistically significant difference was found between the low- dose group and the model group as well as between the middle- and high- dose groups( P 〉0. 05,P 〉0. 05). Conclusions Huxinkang can decrease NF- κB in artery plaque.
机构地区 湖南中医药大学
出处 《实用预防医学》 CAS 2015年第5期613-614,共2页 Practical Preventive Medicine
基金 湖南省教育厅科学研究项目(09B074) 湖南省中药粉体与创新药物研究省部共建国家重点实验室培育基地开放基金项目(ZYFT201304)
关键词 护心康 动脉粥样硬化 NF-ΚB Huxinkang Atherosclerosis Rabbit NF- κB
  • 相关文献

参考文献7

二级参考文献27

  • 1[1]Koenig W,Sund M,FrohlichM,et al.Creactive protein,a sensitive marker of Inflamation,predicts future risk of coronary heart disease in initially healthy midge aged men:results from the MONICA Augsburg cohort study (1984-1992)[J].Circulation,1999,19(1):237-242.
  • 2[4]Musial J,PujakA,UndersA,et al.Thrombinogeneration markers an d coronary heart disease risk factors in a Polish population sample[J].Thromb Haemost,1997,77(5):697.
  • 3Ross R.The pathogenesis of atherosclerosis:a perspective for the 1990s[J].Nature,1993,363:801-809.
  • 4Blake GJ,Ridker PM.Novei clinical markers of vascular wall inflammation[J].Circ Res,2001,89:763-771.
  • 5叶任高 陆再英.内科学[M](第五版)[M].北京人民卫生出版社,2001..
  • 6Monaco C,Andreakos E,kiriakidis S,et al.Canonical pathway of nuclear factor kappaB activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis[J].Proc Natl Acad Sci USA,2004,101(15):5634-5639.
  • 7Wilson SH,Best PJ,Edwards WD,et al.Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris[J].Atherosclerosis,2002,160(1):147-153.
  • 8Ghosh S,Hayden MS.New regulators of NF-kappaB in inflammation[J].Nat Rev Immunol,2008,8(11):837-848.
  • 9Guo RW,Yang LX,Wang H,et al.Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells[J].Regul Pept,2008,147(1-3):37-44.
  • 10Ross R.Atherosclerosis:an inflammatory disease[J].N Engl J Med,1999,340(2):115-126.

共引文献34

同被引文献50

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部